| 摘要 |
<p>Fusion-point spanning peptides, for example BCR-ABL fusion breakpoint peptides associate with chronic myelogenous leukemia (CML), bind major histocompatibility complex molecules, such as HLA class I molecules, and induce cytotoxic T cell proliferation. The breakpoint peptides can be used as vaccines.</p> |
